About Us

We work with our clients to define the level of investigation warranted for each project and design a plan that meets their key goals as quickly and efficiently as possible.

Brief Summary of Founders’ Experience

  • Extremely experienced management team with well over 30-yrs of experience each in Healthcare and Healthcare Services
  • Negotiated business partnerships, joint ventures, co-development agreements, co-marketing agreements and strategic alliances globally
  • Extensive complimentary global Business, Operations, R&D, Finance and Commercial skill sets
  • Direct hands-on experience in acquiring, merging and integrating CRO’s globally
  • Direct hands-on experience in buying & selling companies and products
  • Direct experience in conducting due diligence of both Healthcare product and service companies
  • Efficiently raised >$50MM in various acquisition endeavors from PEGs, VCs
  • Have built and run global companies with revenues in excess of $300MM
  • Worked and lived outside the US (EU & South Africa)
  • Start-up and turn-around experience
  • Have built and developed enabling technology/IT systems and companies
  • Direct experience in Chapter 11 filing, restructuring and emergence
  • Have built Advisory Boards and broad networks of scientific, medical, technical and IT consultants/advisors
  • Extensive global networks in the Pharma, CRO, Biotech, Financial, and investment communities

Rxcel Partners, LLP on LinkedIn

Management:

+ James Utterback

Founder & Chairman

James Utterback on LinkedIn

Record of accelerating growth, launching new business lines and buying/integrating companies

  • Consulting firm assisting international CROs to develop strategies for the U.S. market. Clients have included Russian, Indian, Australian, Baltic region and Mexico-based clinical development services companies
  • HC Services due diligence and market and competitor assessment for VC's and PE firms
  • CRO market due diligence assistance for PEs and VCs – exposure to global CRO market and transaction opportunities
  • Turnaround situation: grew revenue from $38 million with a loss of $3 million to $58 million in revenues and $2 million in EBITDA
  • Rebuilt senior leadership team
  • Successfully sold to Premier Research Group, Ltd.
  • Responsible for maximizing revenue and market share of Covance’s top 10 clients representing 38% of total corporate revenue ($300 million)
  • Opened offices across Asia, Latin America and South Africa and acquired Australian development company
  • Grew regional P&Ls from $10 million to $60 million in three years
  • Completed strategic deals with the governments of Korea, China and Taiwan
  • Expanded Japanese client base by $40 million (>200%) in three years
  • Acquired and built Clinical Packaging and Distribution businesses in the U.S., UK and Switzerland (now a $400 million business owned by Fisher)
  • CEO of Sub-Saharan Africa: managed five countries in Rx, OTC and hospital product businesses
  • Brought RPR’s capabilities to Africa in the field of vaccines, generics and diagnostic imaging agents
  • Led Human Capital and Communication functions globally across as RPR Corporate Officer in Paris, led integration across 40+ markets following Rorer and Rhone Poulenc merger